Clinical Trials – Cross-Border Access

Ideally, all eligible patients in a given country should have equal access to clinical trials, independent of geographic location or socio-economic circumstances. Failing that, cross-border access to clinical trials remains an important access road for patients. On this page, updated resources regarding cross-border access to clinical trials will regularly be made available.



Department of Medical Oncology
Leiden University Medical Center (LUMC)
Albinusdreef 2
2333 ZA Leiden


Project Manager

Funded by the European Union

Grant no. 101079984